Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-860
Closed -$40.5K 913
2022
Q4
$40.5K Buy
860
+114
+15% +$5.79K ﹤0.01% 904
2022
Q3
$30K Sell
746
-474
-39% -$24.2K ﹤0.01% 925
2022
Q2
$46K Buy
+1,220
New +$44.3K ﹤0.01% 932

Other funds holding AGEN

Royce & Associates's AGEN Position: Q1 2023 in Review

Royce & Associates sold out of Agenus (AGEN) in Q1 2023, closing a stake of 860 shares — an estimated $40.5K sold.

Royce & Associates first reported a position in AGEN in Q2 2022 and held it in 3 quarters. The position peaked at $46K in Q2 2022. 157 funds tracked by Wall St. Rank hold AGEN as of Q1 2023.

  • Royce & Associates reported no remaining Agenus position as of Q1 2023 after selling out during the quarter.
  • Royce & Associates sold 860 Agenus shares in Q1 2023, an estimated $40.5K.
  • Royce & Associates first reported a position in Agenus in Q2 2022 and held it in 3 quarters.
  • Royce & Associates's Agenus position peaked at $46K in Q2 2022.
  • 157 funds tracked by Wall St. Rank held Agenus as of Q1 2023.

Based on Royce & Associates's 13F filing for Q1 2023, filed 4 May 2023.